At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 35 enrolled
Drug / intervention
Botox +1 moredrug
Likely dose
Botox 10 unitsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Itch Relieving Effect of Botox: a Study in Healthy Subjects
In Brief
A Phase 2 clinical trial evaluating Botox and Saline for Pruritus. Completed, enrolled 35 participants.
Detailed Summary
The purpose of this study is to determine if Botox is effective in the treatment of an experimentally induced itch that mimics chronic itch in healthy volunteers.
Study Details
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 2015
Enrollment StartFeb 2016
Primary CompletionJul 2016
Study CompletionJan 2017
TodayJul 2026
First PostedDec 24, 2015
Enrollment StartFeb 1, 2016
Primary CompletionJul 1, 2016
Study CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 10.5 years ago
Interventions
Botoxdrug
10 units of Botox will be intradermally injected into one 4x4cm area on the volar forearm on 1st study visit.
Salinedrug
10 units of the Saline vehicle will be intradermally injected into one 4x4cm area on the contralateral volar forearm on the 1st study visit.